REVIEW
|
doi:10.20944/preprints202006.0074.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
COVID-19; myasthenia gravis; respiratory management
Online: 7 June 2020 (09:28:09 CEST)
BRIEF REPORT
|
doi:10.20944/preprints202408.0091.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
myasthenia gravis; epilepsy; autoimmunity; comorbidity; focal epilepsy; selenium
Online: 2 August 2024 (02:52:59 CEST)
REVIEW
|
doi:10.20944/preprints202005.0378.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
intestinal flora; myasthenia gravis; research progress; autoimmune disease; EAMG
Online: 23 May 2020 (16:40:23 CEST)
ARTICLE
|
doi:10.20944/preprints202406.2015.v1
Subject:
Public Health And Healthcare,
Public Health And Health Services
Keywords:
Myasthenia Gravis; Coping impairment; COPE-NVI-25 questionnaire
Online: 29 June 2024 (06:01:09 CEST)
REVIEW
|
doi:10.20944/preprints202005.0334.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
Human Bregs; IL-10; IL-35; TGF- ß; myasthenia gravis; Bregs expansion
Online: 21 May 2020 (03:55:17 CEST)
ARTICLE
|
doi:10.20944/preprints202310.0185.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
monoclonal antibodies; myasthenia gravis; bioinformatics; mechanism of action; IMGT
Online: 4 October 2023 (03:54:47 CEST)
ARTICLE
|
doi:10.20944/preprints202006.0093.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
myasthenia gravis; thymic stromal lymphopoietin; regulatory T cells; TGF- β; IL-10
Online: 7 June 2020 (15:00:37 CEST)
REVIEW
|
doi:10.20944/preprints202404.1538.v2
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
Myasthenia gravis (MG); age and sex/gender; two different forms; genetic and epigenetic factors
Online: 30 April 2024 (11:46:00 CEST)
REVIEW
|
doi:10.20944/preprints202402.1614.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
autoimmune diseases; type 2 hypersensitivity; Tr1; SLE; Myasthenia gravis; Grave’ s disease; GvHD; Sjogren’ s syndrome; AIHA; ITP; dermatomyositis
Online: 28 February 2024 (13:48:04 CET)
ARTICLE
|
doi:10.20944/preprints201809.0591.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
adverse events; immune checkpoint inhibitor; myasthenia gravis; myopathy; neuropathy; nivolumab; pembrolizumab
Online: 29 September 2018 (11:28:00 CEST)